{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T04:20:52Z","timestamp":1773030052395,"version":"3.50.1"},"reference-count":86,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>COVID-19 has become a pandemic with higher morbidity and mortality rates\nafter its start from Wuhan city of China. The infection by RNA virus, also known as SARS-CoV-2 or\n2019-nCoV, from the beta class of coronaviruses, has been found to be responsible for COVID-19.\nStructural analysis and evidences have been indicated that interaction between a segment of receptor\nbinding domain (RBD) from S protein of the virus and human angiotensin-converting enzyme 2\n(hACE2) is essential for cellular entry of the virus.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The current review sheds light on structural aspects for the inhibition of RBD-hACE2 interaction\nmediated cellular entry of SARS-CoV-2.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The present study provides a critical review of recently published information on RBDhACE2\ninteraction and its inhibitors to control SARS-CoV-2 infection. The review highlighted the\nstructural aspects of the interaction between RBD-hACE2 and involved amino acid residues.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Recently, several studies are being conducted for the inhibition of the SARS-CoV-2 attachment\nand entry to the human cellular system. One of the important targets for viral invasion is its\nbinding with cell surface receptor, hACE2, through RBD on S-protein. Mimicking of three residues\non ACE2 (Lys31, Glu35 and Lys353 on B chain) provided a hot target directed strategy for the inhibition\nof early attachment of the virus to the cell. Early screening of peptidic or non-peptidic molecules\nfor the inhibition of RBD-hACE2 interaction has raised the hope for potential therapeutics against\nCOVID-19. The higher affinity of molecules toward RBD than ACE2 is an important factor for selectivity\nand minimization of ACE2 related adverse events on the cardiovascular system, brain, kidney,\nand foetus development during pregnancy.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Inhibition of RBD-hACE2 interaction by different molecular scaffolds can be used as a\npreferred strategy for control of SARS-CoV-2 infection. Recently, published reports pointed out\nLys31, Glu35 and Lys353 on the B chain of ACE2 as crucial residues for mimicking and design of\nnovel molecules as inhibitors SARS-CoV-2 attachment to human cells. Moreover, some recently identified\nRBD-hACE2 interaction inhibitors have also been described with their protein binding pattern\nand potencies (IC50 values), which will help for further improvement in the selectivity.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557520666201117111259","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T04:32:07Z","timestamp":1605760327000},"page":"689-703","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19)"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3544-8791","authenticated-orcid":true,"given":"Surendra Kumar","family":"Nayak","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar- Delhi G.T. Road (NH-1), Phagwara, Punjab-144401,India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"Zhou P.","year":"2020","unstructured":"Zhou P.; Yang X-L.; Wang X-G.; Hu B.; Zhang L.; Zhang W.; Si H-R.; Zhu Y.; Li B.; Huang C-L.; Chen H-D.; Chen J.; Luo Y.; Guo H.; Jiang R-D.; Liu M-Q.; Chen Y.; Shen X-R.; Wang X.; Zheng X-S.; Zhao K.; Chen Q-J.; Deng F.; Liu L-L.; Yan B.; Zhan F-X.; Wang Y-Y.; Xiao G-F.; Shi Z-L.; A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020,579(7798),270-273","journal-title":"Nature"},{"key":"ref=2","first-page":"948","volume":"26","author":"Kim G-U.","year":"2020","unstructured":"Kim G-U.; Kim M-J.; Ra S.H.; Lee J.; Bae S.; Jung J.; Kim S-H.; Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19. Clin Microbiol Infect 2020,26(7),948","journal-title":"Clin Microbiol Infect"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.7326\/M20-0504","volume":"172","author":"Lauer S.A.","year":"2020","unstructured":"Lauer S.A.; Grantz K.H.; Bi Q.; Jones F.K.; Zheng Q.; Meredith H.R.; Azman A.S.; Reich N.G.; Lessler J.; The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application. Ann Intern Med 2020,172(9),577-582","journal-title":"Ann Intern Med"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30558-4","volume":"395","author":"Wang T.","year":"2020","unstructured":"Wang T.; Du Z.; Zhu F.; Cao Z.; An Y.; Gao Y.; Jiang B.; Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet 2020,395(10228)","journal-title":"Lancet"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s11427-020-1661-4","volume":"63","author":"Hu Z.","year":"2020","unstructured":"Hu Z.; Song C.; Xu C.; Jin G.; Chen Y.; Xu X.; Ma H.; Chen W.; Lin Y.; Zheng Y.; Wang J.; Hu Z.; Yi Y.; Shen H.; Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci 2020,63(5),706-711","journal-title":"Sci China Life Sci"},{"key":"ref=6","unstructured":"U.S. Food and Drug Administration Coronavirus (COVID-19) Update: Daily Roundup 2020.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-daily-roundup-march-30-2020"},{"key":"ref=7","unstructured":"U.S. National Library of Medicine COVID-19 Studies from the World Health Organization Database  clinicaltrials.gov\/ct2\/who_table"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.tim.2013.05.005","volume":"21","author":"Chan J.F-W.","year":"2013","unstructured":"Chan J.F-W.; To K.K-W.; Tse H.; Jin D-Y.; Yuen K-Y.; Interspecies transmission and emergence of novel viruses: Lessons from bats and birds. Trends Microbiol 2013,21(10),544-555","journal-title":"Trends Microbiol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"Lu R.","year":"2020","unstructured":"Lu R.; Zhao X.; Li J.; Niu P.; Yang B.; Wu H.; Wang W.; Song H.; Huang B.; Zhu N.; Bi Y.; Ma X.; Zhan F.; Wang L.; Hu T.; Zhou H.; Hu Z.; Zhou W.; Zhao L.; Chen J.; Meng Y.; Wang J.; Lin Y.; Yuan J.; Xie Z.; Ma J.; Liu W.J.; Wang D.; Xu W.; Holmes E.C.; Gao G.F.; Wu G.; Chen W.; Shi W.; Tan W.; Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020,395(10224),565-574","journal-title":"Lancet"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/18715265113139990024","volume":"13","author":"Zhao Q.","year":"2013","unstructured":"Zhao Q.; Weber E.; Yang H.; Drug targets for rational design against emerging coronaviruses. Infect Disord Drug Targets 2013,13(2),116-127","journal-title":"Infect Disord Drug Targets"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/s41467-020-16256-y","volume":"11","author":"Wang C.","year":"2020","unstructured":"Wang C.; Li W.; Drabek D.; Okba N.M.A.; van Haperen R.; Osterhaus A.D.M.E.; van Kuppeveld F.J.M.; Haagmans B.L.; Grosveld F.; Bosch B-J.; A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun 2020,11(1),2251","journal-title":"Nat Commun"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","volume":"11","author":"Ou X.","year":"2020","unstructured":"Ou X.; Liu Y.; Lei X.; Li P.; Mi D.; Ren L.; Guo L.; Guo R.; Chen T.; Hu J.; Xiang Z.; Mu Z.; Chen X.; Chen J.; Hu K.; Jin Q.; Wang J.; Qian Z.; Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 2020,11(1),1620","journal-title":"Nat Commun"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"Walls A.C.","year":"2020","unstructured":"Walls A.C.; Park Y-J.; Tortorici M.A.; Wall A.; McGuire A.T.; Veesler D.; Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 2020,181(2),281-292","journal-title":"Cell"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"Wrapp D.","year":"2020","unstructured":"Wrapp D.; Wang N.; Corbett K.S.; Goldsmith J.A.; Hsieh C.L.; Abiona O.; Graham B.S.; McLellan J.S.; Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020,367(6483),1260-1263","journal-title":"Science"},{"key":"ref=15","unstructured":"https:\/\/www.discngine.com\/blog\/2020\/3\/27\/sars-cov-2-2-from-the-viral-genome-towards-protein-structures"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pbiomolbio.2020.04.002","volume":"155","author":"Sohaila A.","year":"2020","unstructured":"Sohaila A.; Nutini A.; Forecasting the timeframe of coronavirus and human cells interaction with reverse engineering. Prog Biophys Mol Biol 2020,155,29-35","journal-title":"Prog Biophys Mol Biol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3201\/eid2607.200841","volume":"26","author":"Okba N.M.A.","year":"2020","unstructured":"Okba N.M.A.; Muller M.A.; Li W.; Wang C.; GeurtsvanKessel, C.H.; Corman, V.M.; Lamers, M.M.; Sikkema, R.S.; de Bruin, E.; Chandler, F.D.; Yazdanpanah, Y.; Hingrat, Q.L.; Descamps, D.; Houhou-Fidouh, N.; Reusken, C.B.E.M.; Bosch, B.-J.; Drosten, C.; Koopmans, M.P.G.; Haagmans, B.L. SARS-CoV-2 specific antibody responses in COVID-19 patients. Emerg Infect Dis 2020,26(7),1478-1488","journal-title":"Emerg Infect Dis"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"Gordon D.E.A.","year":"2020","unstructured":"Gordon D.E.A.; SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing. Nature 2020,583,459-468","journal-title":"Nature"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"Hoffmann M.","year":"2020","unstructured":"Hoffmann M.; Kleine-Weber H.; Schroeder S.; Kr\u00fcger N.; Herrler T.; Erichsen S.; Schiergens T.S.; Herrler G.; Wu N-H.; Nitsche A.; M\u00fcller M.A.; Drosten C.; P\u00f6hlmann S.; SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020,181(2),271-280","journal-title":"Cell"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"e00127","DOI":"10.1128\/JVI.00127-20","volume":"94","author":"Wan Y.","year":"2020","unstructured":"Wan Y.; Shang J.; Graham R.; Baric R.S.; Li F.; Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J Virol 2020,94(7),e00127-e00120","journal-title":"J Virol"},{"key":"ref=21","author":"Cascella M.","year":"2020","unstructured":"Cascella M.; Rajnik M.; Cuomo A.; Dulebohn S.C.; Napoli R.D.;  Features, evaluation and treatment coronavirus (COVID-19) StatPearls Publishing (internet) 2020","journal-title":"Features, evaluation and treatment coronavirus (COVID-19) StatPearls Publishing (internet)"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jcv.2020.104350","volume":"126","author":"Skarstein Kolberg E.","year":"2020","unstructured":"Skarstein Kolberg E.; ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease. J Clin Virol 2020,126,104-350","journal-title":"J Clin Virol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"6984","DOI":"10.1128\/JVI.00442-08","volume":"82","author":"Li F.","year":"2008","unstructured":"Li F.; Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections. J Virol 2008,82(14),6984-6991","journal-title":"J Virol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"Shang J.","year":"2020","unstructured":"Shang J.; Ye G.; Shi K.; Wan Y.; Luo C.; Aihara H.; Geng Q.; Auerbach A.; Li F.; Structural basis of receptor recognition by SARS-CoV-2. Nature 2020,581(7807),221-224","journal-title":"Nature"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"Yan R.","year":"2020","unstructured":"Yan R.; Zhang Y.; Li Y.; Xia L.; Guo Y.; Zhou Q.; Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020,367(6485),1444-1448","journal-title":"Science"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0165-6147(00)01584-4","volume":"22","author":"Terstappen G.C.","year":"2001","unstructured":"Terstappen G.C.; Reggiani A.; In silico research in drug discovery. Trends Pharmacol Sci 2001,22(1),23-26","journal-title":"Trends Pharmacol Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"8312","DOI":"10.1021\/acsomega.0c00772","volume":"5","author":"Thuy B.T.P.","year":"2020","unstructured":"Thuy B.T.P.; My T.T.A.; Hai N.T.T.; Hieu L.T.; Hoa T.T.; Thi Phuong Loan H.; Triet N.T.; Anh T.T.V.; Quy P.T.; Tat P.V.; Hue N.V.; Quang D.T.; Trung N.T.; Tung V.T.; Huynh L.K.; Nhung N.T.A.; Investigation into SARS-CoV-2 resistance of compounds in garlic essential oil. ACS Omega 2020,5(14),8312-8320","journal-title":"ACS Omega"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","volume":"30","author":"Xia S.","year":"2020","unstructured":"Xia S.; Liu M.; Wang C.; Xu W.; Lan Q.; Feng S.; Qi F.; Bao L.; Du L.; Liu S.; Qin C.; Sun F.; Shi Z.; Zhu Y.; Jiang S.; Lu L.; Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res 2020,30(4),343-355","journal-title":"Cell Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1021\/acsnano.0c02857","volume":"14","author":"Han Y.","year":"2020","unstructured":"Han Y.; Kr\u00e1l P.; Computational design of ACE2-based peptide inhibitors of SARS-CoV-2. ACS Nano 2020,14(4),5143-5147","journal-title":"ACS Nano"},{"key":"ref=30","first-page":"2020010358","author":"Chen H.","year":"2020","unstructured":"Chen H.; Du Q.;  Potential natural compounds for preventing 2019-nCoV infection 2020,2020010358","journal-title":"Potential natural compounds for preventing 2019-nCoV infection"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1038\/srep05452","volume":"4","author":"Moghaddam E.","year":"2014","unstructured":"Moghaddam E.; Teoh B.T.; Sam S.S.; Lani R.; Hassandarvish P.; Chik Z.; Yueh A.; Abubakar S.; Zandi K.; Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci Rep 2014,4,5452","journal-title":"Sci Rep"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2174\/15701786113109990046","volume":"10","author":"Shen M-Z.","year":"2013","unstructured":"Shen M-Z.; Shi Z-H.; Li N-G.; Tang H.; Shi Q-P.; Tang Y-P.; Yang J-P.; Duan J-A.; Efficient synthesis of 6-O-methyl-scutellarein from scutellarin via selective methylation. Lett Org Chem 2013,10(10),733-737","journal-title":"Lett Org Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"69421","DOI":"10.1039\/C6RA16640G","volume":"6","author":"Ahmadi A.","year":"2016","unstructured":"Ahmadi A.; Hassandarvish P.; Lani R.; Yadollahi P.; Jokar A.; Bakar S.A.; Zandi K.; Inhibition of chikungunya virus replication by hesperetin and naringenin. RSC Adv 2016,6,69421-69430","journal-title":"RSC Adv"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1016\/0031-9422(74)80243-8","volume":"13","author":"Kristensen I.","year":"1974","unstructured":"Kristensen I.; Larsen P.O.; Azetidine-2-carboxylic acid derivatives from seeds of Fagus silvatica L. and a revised structure for nicotianamine. Phytochemistry 1974,13(12),2791-2798","journal-title":"Phytochemistry"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/2210289201102010064","volume":"2","author":"Polyakov N.E.","year":"2011","unstructured":"Polyakov N.E.; Leshina T.V.; Glycyrrhizic acid as a novel drug delivery vector: Synergy of drug transport and efficacy. Open Conf Proc J 2011,2,64-72","journal-title":"Open Conf Proc J"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3109\/13880209.2011.608076","volume":"50","author":"Deng Y.F.","year":"2012","unstructured":"Deng Y.F.; Aluko R.E.; Jin Q.; Zhang Y.; Yuan L.J.; Inhibitory activities of baicalin against renin and angiotensin-converting enzyme. Pharm Biol 2012,50(4),401-406","journal-title":"Pharm Biol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcv.2004.03.003","volume":"31","author":"Chen F.","year":"2004","unstructured":"Chen F.; Chan K.H.; Jiang Y.; Kao R.Y.; Lu H.T.; Fan K.W.; Cheng V.C.; Tsui W.H.; Hung I.F.; Lee T.S.; Guan Y.; Peiris J.S.; Yuen K.Y.; In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol 2004,31(1),69-75","journal-title":"J Clin Virol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e0146","DOI":"10.1371\/journal.pone.0146197","volume":"11","author":"Wang W.","year":"2016","unstructured":"Wang W.; Ma X.; Han J.; Zhou M.; Ren H.; Pan Q.; Zheng C.; Zheng Q.; Neuroprotective effect of scutellarin on ischemic cerebral injury by down-regulating the expression of angiotensin-converting enzyme and AT1 receptor. PLoS One 2016,11(1),e0146-e0197","journal-title":"PLoS One"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.antiviral.2005.07.002","volume":"68","author":"Lin C.W.","year":"2005","unstructured":"Lin C.W.; Tsai F.J.; Tsai C.H.; Lai C.C.; Wan L.; Ho T.Y.; Hsieh C.C.; Chao P.D.; Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res 2005,68(1),36-42","journal-title":"Antiviral Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2220\/biomedres.36.219","volume":"36","author":"Takahashi S.","year":"2015","unstructured":"Takahashi S.; Yoshiya T.; Yoshizawa-Kumagaye K.; Sugiyama T.; Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean. Biomed Res 2015,36(3),219-224","journal-title":"Biomed Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/S0140-6736(03)13615-X","volume":"361","author":"Cinatl J.","year":"2003","unstructured":"Cinatl J.; Morgenstern B.; Bauer G.; Chandra P.; Rabenau H.; Doerr H.W.; Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003,361(9374),2045-2046","journal-title":"Lancet"},{"key":"ref=42","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202003.0042.v1","volume":"2020","author":"Senathilake K.S.","year":"2020","unstructured":"Senathilake K.S.; Samarakoon S.R.; Tennekoon K.H.; Virtual screening of inhibitors against spike glycoprotein of 2019 novel corona virus: A drug repurposing approach. Preprints 2020,2020","journal-title":"Preprints"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0731-7085(95)01694-5","volume":"14","author":"Benaji B.","year":"1996","unstructured":"Benaji B.; Dine T.; Luyckx M.; Gressier B.; Brunet C.; Goudaliez F.; Cazin M.; Cazin J.C.; Stability and compatibility studies of zorubicin in intravenous fluids and PVC infusion bags. J Pharm Biomed Anal 1996,14(6),695-705","journal-title":"J Pharm Biomed Anal"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"28775","DOI":"10.1039\/C9RA05572J","volume":"9","author":"Huo J.","year":"2019","unstructured":"Huo J.; Chen X.; Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1\/PI3K\/AKT signaling pathway. RSC Adv 2019,9(49),28775-28782","journal-title":"RSC Adv"},{"key":"ref=45","first-page":"485","volume":"13","author":"Abbas J.R.","year":"2019","unstructured":"Abbas J.R.; Al-Hamadawi H.A.; Effect of chocolate brown HT E155 on some hormones in male albino rats. Eurasia J Biosci 2019,13(1),485-489","journal-title":"Eurasia J Biosci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2174\/157340806777934801","volume":"2","author":"Joanitti G.A.","year":"2006","unstructured":"Joanitti G.A.; Freitas S.M.; Silva L.P.; Proteinaceous protease inhibitors: Structural features and multiple functional faces. Curr Enzym Inhib 2006,2(3),199-217","journal-title":"Curr Enzym Inhib"},{"key":"ref=47","first-page":"1","author":"Xia S.","year":"2020","unstructured":"Xia S.; Zhu Y.; Liu M.; Lan Q.; Xu W.; Wu Y.; Ying T.; Liu S.; Shi Z.; Jiang S.; Lu L.; Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol Immunol 2020,1-3","journal-title":"Cell Mol Immunol"},{"key":"ref=48","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2020.170328","volume":"130","author":"Ling R.","year":"2020","unstructured":"Ling R.; Dai Y.; Huang B.; Huang W.; Yu J.; Lu X.; Jiang Y.; In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2. Peptides 2020,130","journal-title":"Peptides"},{"key":"ref=49","author":"Jena A.B.","year":"2019","unstructured":"Jena A.B.; Kanungo N.; Nayak V.; Chainy G.B.N.; Dandapat J.;  Catechin and curcumin interact with corona 2019","journal-title":"Catechin and curcumin interact with corona"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1570163815666180219115453","volume":"16","author":"Farkhondeh T.","year":"2019","unstructured":"Farkhondeh T.; Yazdi H.S.; Samarghandian S.; The protective effects of green tea catechins in the management of neurodegenerative diseases: A review. Curr Drug Discov Technol 2019,16(1),57-65","journal-title":"Curr Drug Discov Technol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2174\/092986732102131206115810","volume":"21","author":"Marchiani A.","year":"2014","unstructured":"Marchiani A.; Rozzo C.; Fadda A.; Delogu G.; Ruzza P.; Curcumin and curcumin-like molecules: From spice to drugs. Curr Med Chem 2014,21(2),204-222","journal-title":"Curr Med Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3389\/fimmu.2020.01664","volume":"11","author":"Choudhary S.","year":"2020","unstructured":"Choudhary S.; Malik Y.S.; Tomar S.; Identification of SARS-CoV-2 cell entry inhibitors by drug repurposing using in silico structure-based virtual screening approach. Front Immunol 2020,11,1664","journal-title":"Front Immunol"},{"key":"ref=53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.104016","volume":"71","author":"Yu J.W.","year":"2020","unstructured":"Yu J.W.; Wang L.; Bao L.D.; Exploring the active compounds of traditional Mongolian medicine in intervention of novel coronavirus (COVID-19) based on molecular docking method. J Funct Foods 2020,71","journal-title":"J Funct Foods"},{"key":"ref=54","author":"Wu C.","year":"2020","unstructured":"Wu C.; Liu Y.; Yang Y.; Zhang P.; Zhong W.; Wang Y.; Wang Q.; Xu Y.; Li M.; Li X.; Zheng M.; Chen L.; Li H.;  2020"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.2174\/0929867324666170718104412","volume":"25","author":"Tejada S.","year":"2018","unstructured":"Tejada S.; Pinya S.; Martorell M.; Cap\u00f3 X.; Tur J.A.; Pons A.; Sureda A.; Potential anti-inflammatory effects of hesperidin from the genus citrus. Curr Med Chem 2018,25(37),4929-4945","journal-title":"Curr Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.12197934.v1","author":"Unni S.","year":"2020","unstructured":"Unni S.; Aouti S.; Padmanabhan B.; Identification of a potent inhibitor targeting the Spike protein of pandemic human Coronavirus, SARS-CoV-2 by computational methods. ChemRxiv 2020","journal-title":"ChemRxiv"},{"key":"ref=57","first-page":"386","volume":"13","author":"Rider J.A.","year":"1971","unstructured":"Rider J.A.; Treatment of acute and chronic constipation with bisoxatin acetate and bisacodyl. Double-blind crossover study. Curr Ther Res Clin Exp 1971,13(6),386-392","journal-title":"Curr Ther Res Clin Exp"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.antiviral.2006.04.014","volume":"74","author":"Ho T.Y.","year":"2007","unstructured":"Ho T.Y.; Wu S.L.; Chen J.C.; Li C.C.; Hsiang C.Y.; Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res 2007,74(2),92-101","journal-title":"Antiviral Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1469-8137.2002.00459.x","volume":"155","author":"Izhaki I.","year":"2002","unstructured":"Izhaki I.; Emodin- a secondary metabolite with multiple ecological functions in higher plants. New Phytol 2002,155(2),205-217","journal-title":"New Phytol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2174\/1573412914666180710114458","volume":"15","author":"Karadurmus L.","year":"2019","unstructured":"Karadurmus L.; K\u0131r D.; Kurbanoglu S.; Ozkan S.A.; Electrochemical analysis of antipsychotics. Curr Pharm Anal 2019,15(5),413-428","journal-title":"Curr Pharm Anal"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","volume":"2","author":"Vincent M.J.","year":"2005","unstructured":"Vincent M.J.; Bergeron E.; Benjannet S.; Erickson B.R.; Rollin P.E.; Ksiazek T.G.; Seidah N.G.; Nichol S.T.; Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2005,2,69","journal-title":"Virol J"},{"key":"ref=62","author":"Malagon F.","year":"2016","unstructured":"Malagon F.; Carrasco E.;  2016"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","volume":"81","author":"Crumb W.J.","year":"2016","unstructured":"Crumb W.J.; Vicente J.; Johannesen L.; Strauss D.G.; An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel. J Pharmacol Toxicol Methods 2016,81,251-262","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1073\/pnas.0708153105","volume":"105","author":"Rodr\u00edguez-Menchaca A.A.","year":"2008","unstructured":"Rodr\u00edguez-Menchaca A.A.; Navarro-Polanco R.A.; Ferrer-Villada T.; Rupp J.; Sachse F.B.; Tristani-Firouzi M.; S\u00e1nchez-Chapula J.A.; The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel. Proc Natl Acad Sci USA 2008,105(4),1364-1368","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1365-2125.1986.tb02900.x","volume":"22","author":"Ofori-Adjei D.","year":"1986","unstructured":"Ofori-Adjei D.; Ericsson O.; Lindstr\u00f6m B.; Sj\u00f6qvist F.; Protein binding of chloroquine enantiomers and desethylchloroquine. Br J Clin Pharmacol 1986,22(3),356-358","journal-title":"Br J Clin Pharmacol"},{"key":"ref=66","first-page":"308","volume":"30","author":"Haberkorn A.","year":"1979","unstructured":"Haberkorn A.; Kraft H.P.; Blaschke G.; Antimalarial activity of the optical isomers of chloroquine diphosphate. Tropenmed Parasitol 1979,30(3),308-312","journal-title":"Tropenmed Parasitol"},{"key":"ref=67","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25081834","volume":"25","author":"Lentini G.","year":"2020","unstructured":"Lentini G.; Cavalluzzi M.M.; Habtemariam S.; COVID-19, chloroquine repurposing, and cardiac safety concern: Chirality might help. Molecules 2020,25(8)","journal-title":"Molecules"},{"key":"ref=68","author":"Fantini J.","year":"2020","unstructured":"Fantini J.; Scala C.D.; Chahinian H.; Yahi N.; Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. Int J Antimicrob Agents 2020","journal-title":"Int J Antimicrob Agents"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1074\/jbc.M411122200","volume":"280","author":"Mori T.","year":"2005","unstructured":"Mori T.; O\u2019Keefe B.R.; Sowder R.C.; Bringans S.; Gardella R.; Berg S.; Cochran P.; Turpin J.A.; Buckheit R.W.; McMahon J.B.; Boyd M.R.; Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J Biol Chem 2005,280(10),9345-9353","journal-title":"J Biol Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.str.2006.05.017","volume":"14","author":"Zi\u00f3\u0142kowska N.E.","year":"2006","unstructured":"Zi\u00f3\u0142kowska N.E.; O\u2019Keefe B.R.; Mori T.; Zhu C.; Giomarelli B.; Vojdani F.; Palmer K.E.; McMahon J.B.; Wlodawer A.; Domain-swapped structure of the potent antiviral protein griffithsin and its mode of carbohydrate binding. Structure 2006,14(7),1127-1135","journal-title":"Structure"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1128\/JVI.02322-09","volume":"84","author":"O\u2019Keefe B.R.","year":"2010","unstructured":"O\u2019Keefe B.R.; Giomarelli B.; Barnard D.L.; Shenoy S.R.; Chan P.K.S.; McMahon J.B.; Palmer K.E.; Barnett B.W.; Meyerholz D.K.; Wohlford-Lenane C.L.; McCray P.B.; Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. J Virol 2010,84(5),2511-2521","journal-title":"J Virol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1073\/pnas.0307140101","volume":"101","author":"Sui J.","year":"2004","unstructured":"Sui J.; Li W.; Murakami A.; Tamin A.; Matthews L.J.; Wong S.K.; Moore M.J.; Tallarico A.S.; Olurinde M.; Choe H.; Anderson L.J.; Bellini W.J.; Farzan M.; Marasco W.A.; Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci USA 2004,101(8),2536-2541","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=73","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104820","volume":"17","author":"Tai W.","year":"2020","unstructured":"Tai W.; Zhang X.; He Y.; Jiang S.; Du L.; Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2. Antiviral Res 2020,17","journal-title":"Antiviral Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1021\/acs.jmedchem.9b01828","volume":"63","author":"Zhang L.","year":"2020","unstructured":"Zhang L.; Lin D.; Kusov Y.; Nian Y.; Ma Q.; Wang J.; von Brunn A.; Leyssen P.; Lanko K.; Neyts J.; de Wilde A.; Snijder E.J.; Liu H.; Hilgenfeld R.; \u03b1-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: Structure-based design, synthesis, and activity assessment. J Med Chem 2020,63(9),4562-4578","journal-title":"J Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1128\/JVI.02114-07","volume":"82","author":"Xue X.","year":"2008","unstructured":"Xue X.; Yu H.; Yang H.; Xue F.; Wu Z.; Shen W.; Li J.; Zhou Z.; Ding Y.; Zhao Q.; Zhang X.C.; Liao M.; Bartlam M.; Rao Z.; Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design. J Virol 2008,82(5),2515-2527","journal-title":"J Virol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1021\/acs.jmedchem.5b01461","volume":"59","author":"Pillaiyar T.","year":"2016","unstructured":"Pillaiyar T.; Manickam M.; Namasivayam V.; Hayashi Y.; Jung S.H.; An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule chemotherapy. J Med Chem 2016,59(14),6595-6628","journal-title":"J Med Chem"},{"key":"ref=77","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.109814","volume":"142","author":"Raha S.","year":"2020","unstructured":"Raha S.; Mallick R.; Basak S.; Duttaroy A.K.; Is copper beneficial for COVID-19 patients? Med Hypotheses 2020,142","journal-title":"Med Hypotheses"},{"key":"ref=78","first-page":"1","author":"Rahman M.T.","year":"2020","unstructured":"Rahman M.T.; Idid S.Z.; Can Zn be a critical element in COVID-19 treatment? Biol Trace Elem Res 2020,1-9","journal-title":"Biol Trace Elem Res"},{"key":"ref=79","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.12673436.v1","author":"Roberto A.","year":"2020","unstructured":"Roberto A.; Kozak, John J.; Gray, Harry B. Copper(II) inhibition of the SARS-CoV-2 main protease. ChemRxiv 2020","journal-title":"ChemRxiv"},{"key":"ref=80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001176","volume":"6","author":"te Velthuis A.J.","year":"2010","unstructured":"te Velthuis A.J.; van den Worm S.H.; Sims A.C.; Baric R.S.; Snijder E.J.; van Hemert M.J.; Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog 2010,6(11)","journal-title":"PLoS Pathog"},{"key":"ref=81","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.12488390.v1","author":"Gil-Moles M.","year":"2020","unstructured":"Gil-Moles M.; Basu U.; Bussing R.; Hoffmeister H.; Turck S.; Varchmin A.; Ott I.; Gold metallodrugs to fight the corona virus: Inhibitory effects on the spike ACE2 interaction and on PLpro protease activity by auranofin and gold organometallics. ChemRxiv 2020","journal-title":"ChemRxiv"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.femsim.2004.11.004","volume":"43","author":"Chaturvedi U.C.","year":"2005","unstructured":"Chaturvedi U.C.; Shrivastava R.; Interaction of viral proteins with metal ions: Role in maintaining the structure and functions of viruses. FEMS Immunol Med Microbiol 2005,43(2),105-114","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"Hamming I.","year":"2004","unstructured":"Hamming I.; Timens W.; Bulthuis M.L.; Lely A.T.; Navis G.; van Goor H.; Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004,203(2),631-637","journal-title":"J Pathol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"Donoghue M.","year":"2000","unstructured":"Donoghue M.; Hsieh F.; Baronas E.; Godbout K.; Gosselin M.; Stagliano N.; Donovan M.; Woolf B.; Robison K.; Jeyaseelan R.; Breitbart R.E.; Acton S.; A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000,87(5),E1-E9","journal-title":"Circ Res"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1124\/molpharm.120.000014","volume":"97","author":"Kabbani N.","year":"2020","unstructured":"Kabbani N.; Olds J.L.; Does COVID19 infect the brain? If so, smokers might be at a higher risk. Mol Pharmacol 2020,97(5),351-353","journal-title":"Mol Pharmacol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1161\/HYPERTENSIONAHA.111.179358","volume":"58","author":"Bharadwaj M.S.","year":"2011","unstructured":"Bharadwaj M.S.; Strawn W.B.; Groban L.; Yamaleyeva L.M.; Chappell M.C.; Horta C.; Atkins K.; Firmes L.; Gurley S.B.; Brosnihan K.B.; Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction. Hypertension 2011,58(5),852-858","journal-title":"Hypertension"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557520666201117111259","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/188081\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557520666201117111259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T07:54:29Z","timestamp":1660463669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/188081\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557520666201117111259","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}